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Objective: Paraplegia remains a serious complication after surgical repair of thoracoabdominal aortic aneurysms. The aim of
this study was to evaluate the neuroprotective efficacy of fasudil, a Rho kinase (ROCK) inhibitor, by reducing the number of
infiltrating cells in the ventral horn and increasing the induction of eNOS against ischemic spinal cord injury in rabbits.
Methods: Eighteen Japanese white rabbits were divided into three groups: saline (group 1, n 7, 4°C) and fasudil (group
2, n 6, 4°C) were immediately infused into the isolated segmental lumbar arteries over 30 seconds after aortic clamping.
Group 3 (n  5) was the sham-operated group. Hind limb function was evaluated 4 and 8 hours, and 1 and 2 days after
15 minutes of transient ischemia. Cell damage was analyzed by hematoxylin and eosin staining and temporal profiles of
endothelial nitric oxide synthase immunoreactivity were performed. The number of intact motor neuron cells and
infiltrating cells in the ventral horn were compared.
Results: Two days after reperfusion, group 2 and group 3 showed better neurologic function, a greater number of intact
motor neuron cells, and a smaller number of infiltrating cells in the ventral horn than group 1. The induction of
endothelial nitric oxide synthase (eNOS) was prolonged up to 2 days after reperfusion in group 2.
Conclusion: These results indicate that fasudil has neuroprotective effects against ischemic spinal cord injury in rabbits by
reducing the number of infiltrating cells in the ventral horn and prolonging the expression of eNOS. (J Vasc Surg 2010;
51:445-52.)
Clinical Relevance: Paraplegia or paralysis caused by spinal cord ischemia remains a devastating and unpredictable
complication after descending and thoracoabdominal aortic surgery. This study has revealed that fasudil has a
neuroprotective effect against ischemic spinal cord injury in rabbits. Inhibition of the Rho/Rho kinase pathway by fasudil
reduces the number of infiltrating cells in the ventral horn and prolongs the expression of eNOS. In the near future, Rho
kinase may be an important therapeutic target for paraplegia induced by spinal cord ischemia.Paraplegia or paralysis caused by spinal cord ischemia
remains a devastating and unpredictable complication after
descending and thoracoabdominal aortic surgery. The re-
ported incidence of paraplegia ranges from 2.9% to 23% for
operations on the thoracic aorta.1 Despite numerous sur-
gical techniques, including systemic deep hypothermia,
distal aortic perfusion, cerebrospinal fluid drainage, inter-
costals artery implantation, use of motor sensory or so-
matosensory-evoked potentials, and pharmacologic inter-
ventions, the complication still cannot be prevented
completely.
The mechanism of acute spinal cord dysfunction is
believed to result from its ischemic damage during cross-
clamping. Ischemia can occur when there is permanent
From the Department of Cardiovascular Surgery, Kyushu University Grad-
uate School of Medicine.
This study was supported in part by grants from the Japanese Ministry of
Education, Science, Sports, Culture, and Technology, Tokyo, Japan (no.
20591650).
Competition of interest: none.
Reprint requests: Yoshihisa Tanoue, MD, PhD, Department of Cardiovas-
cular Surgery, Kyushu University Graduate School of Medicine, 3-1-1,
Maidashi, Higashi-ku, Fukuoka, 812-8582 Japan (e-mail: tanoue@heart.
med.kyushu-u.ac.jp).
The editors and reviewers of this article have no relevant financial relationships
to disclose per the JVS policy that requires reviewers to decline review of any
manuscript for which they may have a competition of interest.
0741-5214/$36.00
Copyright © 2010 by the Society for Vascular Surgery.
doi:10.1016/j.jvs.2009.10.081exclusion of the essential intercostal arterial blood supply to
the spinal cord or temporary interruption of the spinal cord
blood flow.2 To investigate the mechanisms of the vulner-
ability of spinal motor neurons to ischemia, we created a
rabbit model of spinal cord ischemia in which we statisti-
cally analyzed cell damage.
Rho kinase (ROCK), a target protein of the small
guanosine triphosphate (GTP)-bound form of Rho, is a
serine/threonine kinase. Previous studies suggested that
ROCK or increased ROCK activity is involved in the patho-
genesis of various vascular lesions such as smooth muscle
contraction, cell (neutrophil and monocyte) migration, and
endothelial injury through the downregulation of endothelial
nitric oxide synthase (eNOS) activity and production of O2
in neutrophils and vessels.3-5 Therefore, it has been suggested
that ROCK plays an important role in pathologic conditions,
including cerebral and coronary vasospasm,6,7 hypertension,4
vascular inflammation and remodeling8 and arteriosclerosis.3
Nitric oxide (NO), constitutively produced by eNOS,
regulates cerebral blood flow and vascular tone, and pro-
tects against ischemic stroke by increasing collateral flow to
the ischemic area. Indeed, eNOS-deficient mice develop
larger cerebral infarctions after middle cerebral artery oc-
clusion.9 In contrast, augmentation of endothelial NO
production has been shown to decrease the cerebral infarct
area probably by enhancing collateral blood flow.10 Thus,
enhanced eNOS activity could have beneficial effects on
cerebrovascular disease. ROCK inhibitors reverse the
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However, the physiologic relevance of eNOS regulation by
ROCK is unknown.
Fasudil is a ROCK inhibitor (RKI) that has shown
clinical efficacy on cerebral vasospasm in patients after
clipping surgery for aneurysmal subarachnoid hemor-
rhage.12 Recently, it was reported that fasudil improved
neurologic functions significantly reduced the size of the
infarct area and prevented the accumulation of neutrophils
in rat and mouse models of microembolization stroke.10,13
In animal models, fasudil and hydroxyfasudil had efficacy in
the treatment of acute ischemic stroke.13 However, the
possibility that fasudil may have a neuroprotective effect
against spinal cord injury in ischemia has not yet been
examined. The aim of this study, therefore, was to investi-
gate the neuroprotective effect of fasudil by reducing the
number of infiltrating cells in the ventral horn and increas-
ing the induction of eNOS against ischemic spinal cord
injury in rabbits.
MATERIALS AND METHODS
Animal care. This experiment was reviewed by the
Committee on the Ethics of Animal Experiments of the
Faculty of Medicine, Kyushu University, and was carried
out under the “Guidelines for Animal Experiments” of the
Faculty of Medicine, Kyushu University, and the Law (No.
105) and Notification (No. 6) of the Japanese Govern-
ment.
Animal models. Male Japanese white rabbits (KBT
Oriental, Tokyo, Japan) weighing from 2.5 to 3.0 kg were
used for this study. The rabbits were anesthetized with
intramuscular administration of ketamine at a dose of 50
mg/kg and maintained with 2% halothane inhalation. A
continuous intravenous infusion line was secured at the
marginal ear vein with another 24-gauge catheter. An
arterial line was secured in the ear artery with a 24-gauge
catheter to monitor the proximal arterial pressure. The
rectal temperature was kept at 38°C by using a heating
lamp. A median laparotomy was performed, and the ab-
dominal aorta was exposed from just inferior to the left
renal artery to above the bifurcation. After systemic hepa-
rinization (200 U/kg), a 5F catheter was introduced from
the right femoral artery to the abdominal aorta, and the tip
of the catheter was placed between the left renal artery and
the bifurcation.
The abdominal aorta just distal to the left renal artery
was clamped, the femoral catheter was snared around the
bifurcation, and the posterior mesenteric artery was also
clamped with a vascular clip. Thus, the abdominal aorta and
a few pairs of lumbar arteries were isolated for 15 minutes
to produce spinal cord ischemia.14,15 Eighteen rabbits were
divided into three groups: in group 1, (n  7) 5 mL/kg
cold saline (4°C) was infused, and in group 2, (n  6) 5
mL/kg cold saline plus 0.1 mg/kg fasudil (4°C) was in-
fused into the isolated aortic segment via the femoral
arterial catheter over 30 seconds immediately after cross-
clamping. In group 3 (sham operation), sham was simply a
control for the laparotomy since the cross-clamp was notapplied, the catheters were not inserted, and the aorta was
not isolated/perfused. The femoral arterial catheter was
removed after all the clamps were released and the snare
around the bifurcation loosened. Then the abdomen was
closed in two layers.
Spinal cord temperature measurements. Another
10 animals were used to determine the cooling effect and
were divided into two groups (n  5 in each group). In
group 1, 5 mL/kg cold saline (4°C) was infused and in
group 2, 5 mL/kg cold saline plus 0.1 mg/kg fasudil (4°C)
was infused into the isolated aortic segment via the femoral
arterial catheter over 30 seconds immediately after cross-
clamping. To measure the temperature of the spinal cord, a
needle-tip thermistor (PTN-201; Unique Medical Co Ltd,
Tokyo, Japan) was inserted into the central portion of the
spinal cord (L4) with puncture of the dura.15 The spinal
cord temperature and the rectal temperature were simulta-
neously recorded. The temperature was recorded from just
before cross-clamping to 15 minutes after declamping. The
postoperative neurologic assessment was not performed for
these 10 rabbits because the traumatic damage to the spinal
cord resulting from the insertion of a needle-tip thermistor
would have affected the neurologic outcome in the hind
limbs.
Neurologic assessment. Neurologic function was as-
sessed at 4 and 8 hours, and 1 and 2 days after reperfusion.
Two investigators without knowledge of the treatment
independently graded the neurologic function. The motor
function of the hind limbs was graded by using the modi-
fied Tarlov scale (5  normal hop, 4  weak hop, 3  sits
alone, 2  sits with assistance, 1  slight movement, 0 
no movement).
Histopathology and the number of infiltrating cells
in the ventral horn. All animals were killed after the
completion of the neurologic evaluation at 2 days after
reperfusion. Spinal cords between L2 and L3 were quickly
harvested. Sectioned specimens from the lumbar spinal
cord at the level of L2 or L3 were then fixed in 10%
formaldehyde, dehydrated, and embedded in paraffin. The
sections were cut into 5-m-thick slices and stained with
hematoxylin and eosin and examined by light microscopy
to evaluate the number of normal motor neurons and
infiltrating cells in the ventral horn (group 1: n 7, group
2: n 6, group 3: n 5). The number of intact largemotor
neuron cells in the ventral gray matter region was counted
by an observer who was unaware of animal group or neu-
rologic outcome examined each slide. In cases with py-
knotic nuclei, eosinophilic cytoplasm, or (absent nuclear
hematoxylin staining) large motor neuron cells were con-
sidered “necrotic or dead”. When the cells demonstrated
basophilic striping (containing Nissl substance), motor
neuron cells were considered “viable or alive”. The number
of infiltrating cells in the ventral horn of the spinal cord was
counted for each slide as the sum of the cell count on five
fields at 400 magnification.16
Immunohistochemistry. We also performed an im-
munohistochemical study to investigate changes in the
expression of eNOS at 2 days after reperfusion in groups 1,
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antibody (SA-258, 1:200 dilutions; BIOMOL Interna-
tional LP, Exeter, UK) was used for the immunohisto-
chemistry. Spinal cord sections were rinsed in 0.1 M
phosphate-buffered saline (PBS) for 20 minutes, and
blocked in 2% normal horse serum for 2 hours at room
temperature. Then they were incubated with primary anti-
bodies in 10% normal horse serum or 10% normal rabbit
serum and 0.3% Triton-X 100 for 20 hours at 4°C, respec-
tively. After quenching endogenous peroxidase activity by
exposing slides to 0.3% H2O2 and 10% methanol for 20
minutes, the slides were washed in PBS and incubated for 3
hours with biotinylated anti-mouse IgG (PK-6102; Vector
Laboratories, Burlingame, Calif) at 1:200 dilution in PBS
containing 0.018% normal horse and rabbit serum. Subse-
quently they were incubated with avidin-biotin-horseradish
peroxidase complex (PK-6102; Vector Laboratories). The
slices were colored with DAB/H2O2 solution, and the
cytoplasm was counterstained with hematoxylin. To deter-
mine specific binding of antibody for the protein, a set of
sections were stained in a similar way without the primary
antibody. Staining was categorized in four grades in the
following manner: no staining (), slight staining (),
moderate staining (), or dense staining (2).
Statistical analysis. All results were presented as
mean  standard deviation. Statistical analyses of the neu-
rologic score and the cell number were performed by using
one-way analysis of variance and Bonferroni’s multiple
comparison test to adequately identify which group differ-
ences resulted in a significant P value (.05). In regard to
cooling efficiency of the spinal cord, the random-coefficient
growth curve model was applied for the analysis of repeated
measurements.
RESULTS
Physiologic status. No significant differences were
noted in the rectal temperature or the mean arterial pres-
sure of the proximal and the distal aorta among groups
during operation (P  .05; Table I).
Cooling efficiency. In both groups, the spinal cord
temperature decreased rapidly after saline or saline plus
fasudil (0.1 mg/kg) were infused into the isolated aortic
segment. In group 1, the spinal cord temperature decreased
by a maximum 2.1  0.51°C. In group 2, the spinal cord
temperature decreased by amaximum 2.5 0.75°C. There
was no significant difference in the spinal cord temperature
between the two groups at each time point.
Neurologic outcome. The individual neurologic
scores of the three groups at 4 and 8 hours, and 1 and 2 days
after reperfusion are shown in Fig 1. The animals in the
sham-operated group showed no neurologic deficits, and
their neurologic scores were 5.0  0 when observed 4 and
8 hours, and 1 and 2 days after reperfusion (Fig 1). The
Tarlov scores were 3.9  0.4 and 4.2  0.4 at 4 hours;
3.9 0.4 and 4.3 0.5 at 8 hours; 2.6 1.8 and 4.5 0.8
at 1 day; and 1.7  1.9 and 4.3  1.2 at 2 days after
reperfusion for groups 1 and 2, respectively. The score was
significantly higher in group 2 than group 1 at 1 and 2 days(P .022 and P .014, respectively). However the scores
at 4 and 8 hours were not significantly different between
groups 1 and 2. The scores at all time points after surgery
were significantly higher in group 3 than group 1 (P 
.001, P  .001, P  .003, and P  .003, respectively).
Moreover, the score was significantly higher in group 3
than in group 2 at 4 hours (P  .03).
Histopathology and the number of infiltrating cells
in the ventral horn. The histologic appearance of lumbar
spinal cord stained with hematoxylin-eosin is shown in Fig
2, A, and the results of counting viable motor neurons are
summarized in Fig 2, B. In group 1, about half of motor
neurons in the ventral horn were damaged, and the number
of normal motor neurons was significantly smaller than in
group 2 and group 3 at 2 days after reperfusion (P  .014
and P .008, respectively). The number of infiltrating cells
in the ventral horn in group 1 was significantly greater than
group 2 and group 3 at 2 days after reperfusion (113.7 
10.0 cells vs 79.5 10.5 cells and 85 7.0 cells in 5 fields;
P  .001 and P  .001, respectively, Fig 3). However the
number of infiltrating cells in the ventral horn at 2 days after
reperfusion was not significantly different between groups
2 and 3 (Fig 3).
Immunohistochemical study. Table II shows a sum-
mary of the immunohistochemical analysis for each group.
The motor neurons of sham controls and group 1 were
slightly positive for eNOS (Fig 4, A, B). The eNOS immu-
noreactivity was strongly induced in the motor neurons of
group 2 at 2 days after reperfusion (Fig 4, C).
DISCUSSION
In the present study, we demonstrated that fasudil in
cold saline, which was infused into the isolated aortic
segment, can reduce the neurologic damage of spinal cord
ischemia-reperfusion injury in rabbits. The neuroprotective
effect of fasudil was induced by reducing the number of
infiltrating cells in the ventral horn and increasing the
Table I. Physiologic status
Group 1 Group 2 Group 3
Rectal temperature (°C)
Baseline 38.1  0.1 38.1  0.2 38.1  0.1
Ischemia 10 minutes 37.9  0.3 38.0  0.1 —
Reperfusion 15
minutes 38.1  0.2 38.0  0.1 —
Proximal MAP (mm Hg)
Baseline 78  17 86  22 83  17
Ischemia 10 minutes 85  14 92  8 —
Reperfusion 15
minutes 76  18 70  17 —
Distal MAP (mm Hg)
Ischemia 10 minutes 12  2 10  4 —
Values are means  standard deviation.
MAP, mean atrial pressure.
Group 1 (n  7), 5 mL/kg cold saline 4°C was infused; group 2 (n  6,) 5
mL/kg cold saline plus 0.1 mg/kg fasudil 4°C was infused; group 3, (n 5)
sham group.induction of eNOS. We previously reported that an RKI
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tion.17 The present study provides evidence for the first
time that fasudil reduces neurologic injury in a rabbit model
of spinal cord ischemia.
Animal models. Isaka et al15 reported that the groups
which were clamped, only the abdominal aorta just distal to
the left renal artery for 12 and 15 minutes were all paraplegia.
In the present study, we used this animal model to investigate
the neuroprotective effect of fasudil as spinoplegia infused into
an isolated aortic segment after cross-clamping.
The role of ROCK and the relationship between
RKI and eNOS. A recent study demonstrated the sub-
stantial involvement of intracellular signaling pathways me-
diated by small GTP-binding proteins (G proteins), such as
Rho, Ras, Rab, Sarl/Arf, and Ran families.18 The effector
domains of RhoA, RhoB, and RhoC (collectively referred
to here as Rho) have the same amino acid sequence, and
these G proteins seem to have similar intracellular targets.18
Rho is known to modulate Ca2 sensitization of vascular
smooth muscle cells and is thought to act by inhibiting
myosin phosphatase activity.18
ROCK, a target protein of the small GTP-bound form
of Rho, is a serine/threonine kinase that is activated when
bound to the active GTP-bound form of Rho. Previous
studies suggested that ROCKor increased ROCK activity is
Fig 1. Neurologic function assessed with themodified T
in each group. Individual rabbits are represented by soli
sham operation group showed no neurologic deficits, an
8 hours, and 1 and 2 days after reperfusion. The scores at
between group 1 and 2 but the score at 1 and 2 days aft
1 (P  .022 and P  .014, respectively).involved in the pathogenesis of various vascular lesions suchas smooth muscle contraction, cell (neutrophil and mono-
cyte) migration, and endothelial injury through the down-
regulation of eNOS activity and production of O2 in
neutrophils and vessels.3-5 Recently, it was demonstrated
that fasudil and hydroxyfasudil, selective ROCK inhibitors,
increased eNOS expression, and NO production in vitro
and in vivo under ischemic conditions, and led to increased
collateral blood flow, decreased cerebral infarction size, and
improved neurologic deficit score after cerebral ischemia.10
In another experimental study, it was also reported that
increased production of eNOS had a neuroprotective effect
in the spinal cord after transient ischemia in rabbits.19
Although we tried to examine the Western blot analysis for
eNOS in the spinal cord after reperfusion, we could not
detect a band of eNOS. However, in the present study, we
demonstrated that the group which was treated with fasudil
showed more prolonged eNOS immunoreactivity at 2 days
after reperfusion and higher neurologic scores at 1 and 2
days after reperfusion than the group which was not treated
with fasudil. Thus, in the present study, it is suggested that
prolonged expression of eNOS by treatment with fasudil
under ischemic condition improved collateral flow and
microcirculation, and had a neuroprotective effect.
The relationship between RKI and inflammatory
responses. Activated neutrophils have been reported to
score at 4 and 8 hours, and 1 and 2 days after reperfusion
ares, solid triangles, and solid circles. The animals in the
ir neurologic scores were 5.0  0 when observed 4 and
8 hours after reperfusion were not significantly different
erfusion was significantly higher in group 2 than grouparlov
d squ
d the
4 and
er repcontribute to ischemia-reperfusion injury in the brain and
3 (n 
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damage through free radicals, elastase, and cytokines. A
previous study demonstrated that fasudil and hydroxyl
fasudil prevented the inflammatory responses in the post-
ischemic brain by inhibiting neutrophil and monocyte in-
filtration and inhibiting the production of O2 in neutro-
phils and vessels.13 Another study has demonstrated that
long-term concomitant treatment with fasudil markedly
suppresses angiotensin II-induced upregulation of all nico-
tinamide adenine dinucleotide phosphate oxidase sub-
units.22 In the present study, we could not evaluate the
productionof reactive oxygen species (ROS) in the spinal cord
of all groups, but the number of infiltrating cells in the ventral
horn was significantly reduced in the fasudil-treated group
compared to the saline group. These results were compatible
with the previous reports. Fasudil has a neuroprotective effect
through suppression of migration of infiltrating cells.
Hypothermic effect. According to previous reports,
hypothermia with systemic cooling or local cooling has
Fig 2. Histologic findings in the spinal cord at 2 days aft
appearance of lumbar spinal cord stained with hematoxyl
(B) are shown. In group 1, about half of the motor neu
normal motor neurons was significantly smaller compared
and P .008, respectively). Group 1 (n 7): 5 mL/kg c
saline plus 0.1 mg/kg fasudil (4°C) was infused, groupbeen demonstrated to protect the spinal cord motor neu-rons during transient ischemia.15,23 Other studies intro-
duced various methods of local cooling. None of these
methods has been commonly used in clinical applications
because of problems of complexity and risk of eachmethod.
Systemic deep hypothermia is used clinically and is effective
against neuronal ischemia, but systemic deep hypothermia
is associated with a high incidence of cardiac dysfunction
and coagulopathy.24 Mild hypothermia has been shown to
confer protection against histopathologic and metabolic
derangements that follow ischemic injury.25 In the present
study, mild hypothermia is maintained, and the actual
temperature of the spinal cord of rabbits is 2°C to 4°C
colder than the pre-ischemic temperature during ischemia.
In the present study, we also demonstrated that mild hypo-
thermia, even 2°C colder than normal, confers neuropro-
tective effects on the spinal cord motor neurons in the early
phase after reperfusion.
Spinoplegia. We have previously reported that RKI
improves cardiac function after 24-hour heart preserva-
erfusion stained with hematoxylin-eosin. The histologic
sin (A) and the results of counting viable motor neurons
in the ventral horn were damaged, and the number of
roup 2 and group 3 at 2 days after reperfusion (P .014
aline (4°C) was infused, group 2 (n 6): 5 mL/kg cold
5): sham operation. Bar  50 m.er rep
in-eo
rons
to g
old stion.17 In that report, the most effective dose of RKI was
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experiment of 1 mg/kg fasudil supplanted into the spi-
noplegia, such as our previous study which did perform a
dose response curve of fasudil in a cardiac model, this
experiment did not improve neurologic function and pro-
duced profound systemic vasodilation and instability.
Therefore, in the present study, we justified the use of a
single dose of 0.1 mg/kg fasudil which is a dose to mini-
mize changes in the systemic pressure of the rabbits. Spi-
Fig 3. The histologic appearance of lumbar spinal cor
number of infiltrating cells (B) are shown. The number o
in group 2 compared to group 1 (79.5  10.5 cells vs 1
mL/kg cold saline (4°C) was infused, group 2 (n 6): 5
group 3 (n  5): sham operation. Bar  50 m.
Table II. Immunoreactivity for eNOS in the spinal
motor neurons
eNOS
Group 1 Group 2 Group 3
2d  –  2 2 2 
 
, Negative; , subtle positive reaction; , positive reaction; 2, strongly
enhanced reaction; eNOS, endothelial nitric oxide synthase.noplegia of 10mL or 20mL infused into segmental lumbararteries has already been reported.14,15 Thus, in the present
study, spinoplegia of 5 mL/kg (from about 12.5 mL to 15
mL) was infused into segmental lumbar arteries. There was
no significant difference in the amount of spinoplegia be-
tween groups 1 and 2.
Spinoplegia was first described in the report by Svens-
son et al.26 They demonstrated that segmental infusion of a
single dose of cold crystalloid with lidocaine, termed “spi-
noplegia”, was effective in reducing the severity of ischemia
during aortic cross-clamping. Previous studies demon-
strated the effect of various spinoplegia against ischemic
spinal cord injury.14,15 In this experiment, we established a
local cooling model and investigated the reduction of isch-
emic damage to spinal cord motor neurons under regional
mild hypothermia and infusion of fasudil. There was no
significant difference in the direct temperature of the spinal
cord at each time point between the two groups infused
with fasudil or just saline; however, no postoperative neu-
rologic assessment was performed.
A previous study demonstrated that a group of rabbits
ned with hematoxylin-eosin (A) and the results of the
trating cells in the ventral horn was significantly reduced
 10.0 cells in 5 fields; P  .001). Group 1 (n  7): 5
kg cold saline plus 0.1 mg/kg fasudil (4°C) was infused,d stai
f infil
13.7
mL/which was infused with 37°C saline into the isolated aortic
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neurologic score than another group which was infused
with 3°C saline.15 In the present study, the neurologic
scores of the fasudil-treated group and the saline group at 4
and 8 hours, showed comparatively high scores and these
were not significantly different between the two groups.
These results showed that local cooling of the spinal cord,
which was established with infusion of cold reagent, has a
neuroprotective effect at an early stage after reperfusion. At
2 days after reperfusion, however, the fasudil-treated group
showed better neurologic function than the saline group
(P  .014), a greater number of intact motor neuron cells
than the saline group (P  .014), and a smaller number of
infiltrating cells in the ventral horn than the saline group
Fig 4. Immunohistochemical staining for endothelial nitric oxide
synthase (eNOS) in the spinal cord in the sham group 3 (A), group
1 (B), and group 2 (C) at 2 days after reperfusion. The eNOS
immunoreactivity in group 1 was slightly induced at 2 days. The
density of eNOS immunoreactivity in group 2 was stronger than in
group 1 at 2 days. Black arrows show motor neurons that express
immunoreactive eNOS. Bar  50 m.(P  .001). These results demonstrated that fasudil im-proves collateral flow and microcirculation in the spinal
cord under ischemic conditions, and reduces the inflamma-
tory cells (neutrophil and monocyte) migration, thus hav-
ing a neuroprotective effect against spinal cord ischemic
injury in rabbits. Fasudil is a promising additive agent in
spinoplegia.
LIMITATIONS
Although we clearly demonstrated the protective ef-
fects of cold spinoplegia with fasudil against ischemic spinal
cord injury in rabbits, these findings have some limitations.
First, the animal model used in this study is invasive and
complicated. Another control group, which was only
clamped and not perfused with any agent, showed a signif-
icantly lower neurologic score at the early stage after reper-
fusion than other groups infused with cold agent (data not
shown). Most animals of the positive control, which was
only clamped and not perfused with any agent, died within
2 days after reperfusion. In the present study, we used this
animal model to investigate the neuroprotective effect of
fasudil as spinoplegia infused into an isolated aortic seg-
ment after cross-clamping. The use of a less invasive animal
model of transient spinal cord ischemia could obtain more
data about whether the neuroprotective effects of fasudil
are equal when infused intravenously after or during tran-
sient spinal cord ischemia. Second, Western blot analysis
could not identify the activity of eNOS, and so we only
showed more prolonged eNOS immunoreactivity and a
smaller number of infiltrating cells in the ventral horn of
fasudil group at 2 days after reperfusion. Finally, as we
could not measure the collateral flow or microcirculation in
the spinal cord after reperfusion, we are unable to explain
the actual mechanism of the neuroprotective effect of fa-
sudil. Thus, further studies regarding the expression of
eNOS and measurement of the collateral flow or microcir-
culation in the spinal cord after transient ischemia are called
for.
CONCLUSIONS
The mechanisms of Rho/Rho kinase pathway-
mediated spinal cord ischemic injury and infiltrating cell-
mediated spinal cord ischemic injury are not fully under-
stood. Inhibition of the Rho/Rho kinase pathway by fasudil
can alleviate ischemic motor damage by reducing the num-
ber of infiltrating cells in the ventral horn and prolonging
the expression of eNOS. The Rho/Rho kinase pathway,
eNOS, and infiltrating cells may affect the survival and
death-promoting events in spinal cord ischemic injury.
This study has revealed that fasudil has a neuroprotec-
tive effect against ischemic spinal cord injury in rabbits.
Inhibition of the Rho/Rho kinase pathway by fasudil re-
duces the number of infiltrating cells in the ventral horn
and prolongs the expression of eNOS.
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